Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

media

228 POSTS

Exclusive articles:

SKN | SPAC Dynamix IV Files for a $175 Million IPO, Targeting Energy and Power

SPAC Dynamix IV has filed for a $175 million initial public offering, aiming to target high-growth companies in the energy and power sector. The...

SKN | SPAC Idea Acquisition Prices $350 Million IPO, Targeting AI-Driven Software Platforms

Idea Acquisition Corp., a special purpose acquisition company (SPAC) focused on software and artificial intelligence–enabled business models, has priced a $350 million initial public...

SKN | SPAC Metals Acquisition II Files for a $200 Million IPO, Targeting Mining Sector

SPAC Metals Acquisition II has officially filed for an initial public offering, seeking to raise $200 million to pursue acquisitions in the mining sector....

SKN | Polaryx Therapeutics Sets Stage for Market Debut as Vittoria Reshapes Its IPO Strategy

Vittoria is preparing to enter public markets through a revised IPO structure that reflects shifting investor sentiment and tighter capital market conditions. The company...

SKN | V Capital Consulting Group Files for U.S. IPO, Targeting Expansion of Southeast Asia Advisory Platform

Malaysia-based business consulting firm V Capital Consulting Group has filed for a U.S. initial public offering, seeking to raise approximately $15 million as it...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img